Last €8.29 EUR
Change Today +0.082 / 1.00%
Volume 0.0
7BA On Other Exchanges
New York
EN Paris
As of 3:03 AM 09/22/14 All times are local (Market data is delayed by at least 15 minutes).

bioamber inc (7BA) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/5/14 - €10.85
52 Week Low
09/23/13 - €3.47
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BIOAMBER INC (7BA)

bioamber inc (7BA) Related Bloomberg News

View More Bloomberg News

bioamber inc (7BA) Related Businessweek News

No Related Businessweek News Found

bioamber inc (7BA) Details

BioAmber Inc., an industrial biotechnology company, produces and sells bio-succinic acid to customers in various chemical markets in the United States. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into chemicals that are replacements for petroleum-derived chemicals. The company’s bio-succinic acid is used in various applications, including plasticizers, polyurethanes, personal care products, resins and coatings, de-icing and coolant solutions, fine chemicals, lubricants, and food additives, as well as anti-freeze solutions, coolants solvents, water treatment chemicals, laundry tablets and bath salts, artificial leather products, and foams made with recycled polyethylene terephthalate. Its product pipeline also includes bio-succinic acid derivatives, such as 1, 4 butanediol, gamma-butyrolactone, and succinic acid based polyesters. The company sells its products directly to its customers and commercial partners, as well as indirectly through distributor in the Asia-Pacific region. It has strategic relationships with various companies, including Mitsubishi Chemical Corporation for bio-succinic acid. The company was formerly known as DNP Green Technology, Inc. and changed its name to BioAmber Inc. in September 2010. BioAmber Inc. is headquartered in Montreal, Canada.

bioamber inc (7BA) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $632.4K
Chief Commercial Officer
Total Annual Compensation: $298.0K
Executive Vice President of Business Developm...
Total Annual Compensation: $319.3K
Compensation as of Fiscal Year 2013.

bioamber inc (7BA) Key Developments

BioAmber Inc. Presents at Credit Suisse Basic Materials Conference 2014, Sep-16-2014 01:15 PM

BioAmber Inc. Presents at Credit Suisse Basic Materials Conference 2014, Sep-16-2014 01:15 PM. Venue: Credit Suisse, One Madison Avenue - between 23rd and 24th streets, New York, NY 10010, United States. Speakers: Jean-Francois Huc, CEO.

BioAmber Inc. Announces Unaudited Consolidated Earnings Results for the Quarter Ended June 30, 2014

BioAmber Inc. announced unaudited consolidated earnings results for the quarter ended June 30, 2014. For the quarter, the company reported product sales of $415,000 against $1028,000 a year ago. Operating loss was $10,378,000 against $17,678,000 a year ago. Loss before income taxes was $14,136,000 against $7,178,000 a year ago. Net loss attributable to the company shareholders was $13,993,000 or $0.75 basic per share against $7,057,000 or $0.47 basic per share a year ago. Net cash used in operating activities was $3,083,000 against $3,300,000 a year ago. Acquisition of property and equipment was $19,997,000 against $2,074,000 a year ago. Adjusted net loss attributable to the company shareholders was $7,465,000 or $0.40 basic per share against $9,712,000 or $0.65 basic per share a year ago. The decrease in revenue was principally due to sales to two customers in second quarter of 2013 that will not recur until the Sarnia plant comes on line.

BioAmber Inc. to Report Q2, 2014 Results on Aug 07, 2014

BioAmber Inc. announced that they will report Q2, 2014 results at 8:12 PM, GMT Standard Time on Aug 07, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
7BA:GR €8.29 EUR +0.082

7BA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 7BA.
View Industry Companies

Industry Analysis


Industry Average

Valuation 7BA Industry Range
No financial data is available for 7BA.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOAMBER INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at